Shachar Peles - Florida Cancer ...

Dr. Shachar Peles

Claim this profile

Florida Cancer Specialists East

Studies Mixed-Cell Lymphoma
Studies Multiple Myeloma
10 reported clinical trials
41 drugs studied

Area of expertise

1

Mixed-Cell Lymphoma

Shachar Peles has run 4 trials for Mixed-Cell Lymphoma. Some of their research focus areas include:

Stage III
Stage IV
2

Multiple Myeloma

Shachar Peles has run 4 trials for Multiple Myeloma. Some of their research focus areas include:

Stage III
Stage IV

Affiliated Hospitals

Image of trial facility.

Florida Cancer Specialists-East

Image of trial facility.

Florida Cancer Specialists

Clinical Trials Shachar Peles is currently running

Image of trial facility.

Pirtobrutinib vs Ibrutinib

for Chronic Lymphocytic Leukemia

The purpose of Part 1 of this study is to compare the efficacy and safety of pirtobruitinib (LOXO-305) to ibrutinib in participants with CLL/SLL; participants may or may not have already had treatment for their cancer. The purpose of Part 2 of this study evaluates pirtobrutinib monotherapy in treatment-naïve participants with CLL/SLL with 17p deletions. Participation could last up to six years for Part 1. Participation could last up to 2 years for Part 2.

Recruiting

2 awards

Phase 3

Image of trial facility.

Targeted Therapy

for Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

Recruiting

1 award

Phase 2

9 criteria

More about Shachar Peles

Clinical Trial Related

3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical Trials

Treatments Shachar Peles has experience with

  • Pirtobrutinib
  • Rituximab
  • LOXO-305
  • Venetoclax
  • Dasatinib
  • Asciminib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Shachar Peles specialize in?

Is Shachar Peles currently recruiting for clinical trials?

Are there any treatments that Shachar Peles has studied deeply?

What is the best way to schedule an appointment with Shachar Peles?

What is the office address of Shachar Peles?

Is there any support for travel costs?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security